Are T cell ‘engagers’ the next big thing in autoimmune disease treatment?
Engineered antibodies may produce remissions and offer safety benefits over cell therapies that have killed patients
Engineered antibodies may produce remissions and offer safety benefits over cell therapies that have killed patients